HealthDay News — Paternal exposure to valproate during sperm development is not associated with neurodevelopmental disorders (NDDs) in offspring, according to a study published online August 19 in ...

Lisraya is the first oral dual TYK2/JAK1 inhibitor indicated for adults with dermatomyositis, demonstrating significant ...

HealthDay News — Baseline cortical atrophy measured within the early-onset Alzheimer disease (EOAD) signature, a set of predominantly parietotemporal regions showing greater atrophy in EOAD than in ...

Interim Phase 1b/2a trial data support the MKK4 inhibitor's potential to protect hepatocytes and accelerate liver regeneration following surgical resection.

FDA approves updated 2026-2027 COVID-19 vaccine formulations targeting the XFG variant for older adults and high-risk ...

Clinicians may not agree on physical exam findings for youth with community-acquired pneumonia (CAP), according to a study published online August 20 in JAMA Ne ...

Phase 3 RASolute 302 data show daraxonrasib significantly extended overall and progression free survival compared with ...

The FDA has approved Tivicay PD dispersible tablets for combination HIV-1 treatment in full-term neonates weighing at least 2kg.

Mounjaro approval expanded to reduce the risk of major cardiovascular events; The American Academy of Pediatrics has issued updated recommendations for RSV immunization; BTK inhibitor shows promise in ...

FDA clears Zanvastro (zilganersen) as the first disease-modifying therapy for Alexander disease following positive Phase 1-3 trial results.

Updated recommendations are presented to help clinicians decide which medications may be effective for preventing migraine in adults in 2 reports issued by the American Academy of Neurology and ...

FDA adds a boxed warning to ferric carboxymaltose prescribing information, emphasizing severe low phosphate risks and mandatory monitoring protocols.